Choose Excellence for your Radiopharma Production.

Based on 35 years of experience, IBA helps nuclear medicine department to design, build and operate PET centers for the production of radiopharmaceuticals.

找到您的解决方案

找到您需要的核素

事件

新闻

Best wishes from our entire IBA RadioPharma Solutions team!
Best wishes from our entire IBA RadioPharma Solutions team!
查看更多
AlF-peptides labelling method - One process to label them all…
IBA intend to propose commercial kits for AlF-peptide process on Synthera^®+ (IFP, reagents, ancillaries)
查看更多
18F-flotufolastat (previously known as 18F rhPSMA-7.3)
Automated labeling of flotufolastat gallium triflutate with 18F on the IBA Synthera^®+ Platform - a simplified and efficient approach
查看更多
[18F]FES /16α-[18F]-fluoroestradiol
[18F]luoroestradiol / [18F]FES /16α-[18F]-fluoroestradiol. Radiolabeled analog of estradiol used as a contrast agent in the PET imaging of estrogen receptor-positive breast cancer lesions.
查看更多
IBA Reports Third Quarter 2024 Results
IBA, the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announces its business update for the third quarter 2024.
查看更多
Almathera selects IBA to equip Kazakhstan’s first private radiopharmacy and theranostics complex with Cyclone^® KIUBE 300
Almathera selects IBA to equip Kazakhstan’s first private radiopharmacy and theranostics complex with Cyclone^® KIUBE 300
查看更多

重要事件

超过 800 家客户

Synthera^® 放射合成模块安装遍布全球
3 个模块（最多）

在一个热室中
多种示踪剂生产，多次运行
30 Ci （最多）

每次生产运行
用于FDG 生产
超过 300 家客户

回旋加速器运行和支持服务遍布5个洲

Worldwide references

近35年来，著名的诊断和研究中心一直信赖IBA的高技术设备，用于其放射性药物的生产

Convinced? Contact us